PMID- 16679060 OWN - NLM STAT- MEDLINE DCOM- 20061204 LR - 20070621 IS - 1438-4639 (Print) IS - 1438-4639 (Linking) VI - 209 IP - 4 DP - 2006 Jul TI - Surveillance of cystic fibrosis patients with multi-drug resistant Gram-negative rods. PG - 333-6 AB - OBJECTIVES: Although several nosocomial outbreaks with multi-drug resistant Gram-negative bacteria (MRGN) are documented, only few are known about the endemic situation of theses pathogens. Especially cystic fibrosis (CF) patients are known to be at risk for MRGN acquisition. We present surveillance data of endemic MRGN in CF patients from a German university hospital during a 3-year period. METHODS: CF inpatients from 2002 to 2004 were included. A MRGN was defined as a Gram-negative rod of which less than two groups of antibiotics had been tested susceptible. MRGN patients who were admitted more than once were counted each time as a new MRGN case. RESULTS: Three hundred and thirty-nine inpatient cases (109 different patients) with MRGN were enrolled. Two hundred and sixty-seven cases were known to be MRGN positive at the time point of admission, 167 cases were affected by pan-resistant pathogens. P. aeruginosa was the MRGN species detected most frequently. MRGN was detected after 48h of hospital stay in 9 patients. CONCLUSIONS: MRGN surveillance is recommended by several experts but unfortunately only few data has been published. To our knowledge this is the first description of the complete endemic MRGN situation in CF patients. MRGN surveillance is necessary and will be continued in our facility. FAU - Vonberg, Ralf-Peter AU - Vonberg RP AD - Institute for Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Vonberg.Ralf@MH-Hannover.DE FAU - Wolter, Anneke AU - Wolter A FAU - Ziesing, Stefan AU - Ziesing S FAU - Gastmeier, Petra AU - Gastmeier P LA - eng PT - Journal Article DEP - 20060506 PL - Germany TA - Int J Hyg Environ Health JT - International journal of hygiene and environmental health JID - 100898843 RN - 0 (Anti-Bacterial Agents) SB - IM MH - Adolescent MH - Adult MH - Anti-Bacterial Agents/pharmacology MH - Child MH - Child, Preschool MH - Cross Infection/complications/epidemiology/*microbiology MH - Cystic Fibrosis/complications/epidemiology/*microbiology MH - *Drug Resistance, Multiple, Bacterial MH - Female MH - Germany MH - Gram-Negative Bacteria/drug effects/isolation & purification MH - Gram-Negative Bacterial Infections/complications/epidemiology/*microbiology MH - Hospitals, University MH - Humans MH - Infant MH - Infant, Newborn MH - Male MH - Middle Aged EDAT- 2006/05/09 09:00 MHDA- 2006/12/09 09:00 CRDT- 2006/05/09 09:00 PHST- 2005/11/20 00:00 [received] PHST- 2006/02/22 00:00 [revised] PHST- 2006/03/12 00:00 [accepted] PHST- 2006/05/09 09:00 [pubmed] PHST- 2006/12/09 09:00 [medline] PHST- 2006/05/09 09:00 [entrez] AID - S1438-4639(06)00023-X [pii] AID - 10.1016/j.ijheh.2006.03.001 [doi] PST - ppublish SO - Int J Hyg Environ Health. 2006 Jul;209(4):333-6. doi: 10.1016/j.ijheh.2006.03.001. Epub 2006 May 6.